Related Experiment Video
Updated: May 5, 2026

Retroductal Submandibular Gland Instillation and Localized Fractionated Irradiation in a Rat Model of Salivary Hypofunction
Published on: April 24, 2016
Advances in Gene Therapy for Xerostomia: Current Perspectives and Future Directions: A Narrative Review
Muhammad Usman Bilal1, Sarah Alvi2, Fatima Humayune1
1School of Dentistry Shaheed Zulfiqar Ali Bhutto Medical University Islamabad Pakistan.
Background And Aims:
Xerostomia, or dry mouth, significantly impairs quality of life and oral health, particularly in patients subjected to radiation therapy or suffering from systemic disorders. This narrative review summarizes the current evidence on the efficacy and safety of gene therapy interventions for xerostomia, exploring innovative approaches such as viral vector-mediated delivery of aquaporin-1, growth factor-based strategies, and cutting-edge CRISPR techniques.
Methods:
We conducted a comprehensive literature search on gene therapy interventions for xerostomia to synthesize this narrative review.
Results And Conclusion:
A critical evaluation of these studies reveals promising advancements alongside current limitations in medical research, including off-site therapeutic effects, delivery efficiency, and long-term efficacy. This review thus provides a comprehensive perspective on current gene therapy strategies for xerostomia, setting the stage for future research to bridge the gap between experimental therapies and everyday clinical applications.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Gene Therapy
Gene Therapy
Microorganisms in Medicine and Therapeutics
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

